LeMaitre Q1 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500, Nasdaq advance as soft inflation tempers Fed rate-hike bets
- Equity positioning stays overweight, but summer extremes have eased: Barclays
- Oil prices rise on stalled US-Iran talks and tight fuel markets
- Micron reports Q4 today: Why Lynx Equity sees massive upside
- Moderna: Citi says oncology optimism is priced in, cuts rating to sell
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Apple's iOS 27 is blocking Trade Desk ads on Safari, analyst says
- Mattel names Roger Lynch as chairman and CEO, replacing Ynon Kreiz
Lemaitre Vascular (LMAT) Tops Q1 EPS by 2c; Guides Above Consensus
May 2, 2023 4:08 PM EDTLemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $47.1 million versus the consensus estimate of $43.53 million.
GUIDANCE:
Lemaitre Vascular sees Q2 2023 EPS of $0.30-$0.35, versus the consensus of $0.31.... More
